| pubmed-article:9236334 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9236334 | lifeskim:mentions | umls-concept:C1186983 | lld:lifeskim |
| pubmed-article:9236334 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
| pubmed-article:9236334 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:9236334 | lifeskim:mentions | umls-concept:C0449851 | lld:lifeskim |
| pubmed-article:9236334 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9236334 | pubmed:dateCreated | 1997-8-21 | lld:pubmed |
| pubmed-article:9236334 | pubmed:abstractText | Aminooleic acid treatment has been demonstrated to prevent porcine valve calcification and to protect valvular hemodynamic function. Initial enthusiasm was tempered by histologic studies of these AOA valves, which showed cuspal hematomas, structural loosening, and surface roughening. This prompted a systematic review of the AOA treatment process. Unsolubilized particles of alpha aminooleic acid present in the treatment solution were identified as the cause of mechanical abrasion of valve cusps during processing. These particles were eliminated with a revamped protocol, which included filtration of the AOA solution before valve preparation. | lld:pubmed |
| pubmed-article:9236334 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9236334 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9236334 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9236334 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9236334 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9236334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9236334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9236334 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9236334 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9236334 | pubmed:issn | 0003-4975 | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:GirardotJ MJM | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:ChenWW | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:LevyR JRJ | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:SchoenF JFJ | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:HallJ DJD | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:GuytonR ARA | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:GottJ PJP | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:DorseyL MLM | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:GirardotM NMN | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:WhitlarkJ DJD | lld:pubmed |
| pubmed-article:9236334 | pubmed:author | pubmed-author:HorsleyW SWS | lld:pubmed |
| pubmed-article:9236334 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9236334 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:9236334 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9236334 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9236334 | pubmed:pagination | 50-8 | lld:pubmed |
| pubmed-article:9236334 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:meshHeading | pubmed-meshheading:9236334-... | lld:pubmed |
| pubmed-article:9236334 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9236334 | pubmed:articleTitle | Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. | lld:pubmed |
| pubmed-article:9236334 | pubmed:affiliation | Carlyle Fraser Heart Center, Crawford Long Hospital of Emory University, Emory University School of Medicine, Atlanta, Georgia 30365, USA. | lld:pubmed |
| pubmed-article:9236334 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9236334 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9236334 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9236334 | lld:pubmed |
